ABCB1 and ABCG2 expression in the placenta and fetus: An interspecies comparison

Expert Opinion on Drug Metabolism and Toxicology

Volumn 6, Issue 11, 2010, Pages 1385-1398

  Myllynen, Pivi ^a   Kummu, Maria ^a   Sieppi, Elina ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

ABC transporter; ABCB1; ABCG2; fetus; placenta; pregnancy

Indexed keywords

AVERMECTIN; BREAST CANCER RESISTANCE PROTEIN; CIMETIDINE; DIGOXIN; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; SAQUINAVIR;

BIRTH; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CORRELATION ANALYSIS; FETUS (ANATOMY); GENE EXPRESSION; GUINEA PIG; HUMAN; INTESTINE; KIDNEY; LIVER; MEDLINE; NONHUMAN; ORGANOGENESIS; PLACENTA; PREGNANCY; PROTEIN EXPRESSION; RABBIT; REVIEW; SPECIES COMPARISON;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; FETUS; GENE EXPRESSION; GUINEA PIGS; HUMANS; MICE; NEOPLASM PROTEINS; P-GLYCOPROTEIN; PHARMACEUTICAL PREPARATIONS; PLACENTA; PREGNANCY; RABBITS; RATS; SPECIES SPECIFICITY;

CAVIA; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 77958508112     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425255.2010.514264     Document Type: Review

References (102)

1. Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004;43:487-514
2. Mao Q. BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm Res 2008;25:1244-1255
3. Myllynen P, Immonen E, Kummu M, et al. Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol 2009;5:1483-1499
4. Bliek BJ, van Schaik RH, van der Heiden IP, et al. Eurocran Gene-Environment Interaction Group. Maternal medication use, carriership of the ABCB1 3435C > T polymorphism and the risk of a child with cleft lip with or without cleft palate. Am J Med Genet A 2009;149A:2088-2092
5. Lankas GR, Wise LD, Cartwright ME, et al. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 1998;12:457-463
6. Vasilou V, Vasilou K, Nebert DW. Human ATP-binding cassette (ABC) transporter family. Hum Genomics 2009;3:281-290
7. Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 2010;62:1-96
8. International Transporter Consortium, Giacomini KM, Huang SM, et al. Membrane transporters in drug development. Nat Rev Drug Discov 2010;9:215-236
9. Robey RW, To KK, Polgar O, et al. ABCG2: a perspective. Adv Drug Deliv Rev 2009;61:3-13
10. Deeley RG, Westlake C, Cole SP. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 2006;86:849-899
11. Sarkadi B, Homolya L, Szakacs G, Varadi A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev 2006;86:1179-1236
12. Takano M, Yumoto R, Murakami T. Expression and function of efflux drug transporters in the intestine. Pharmacol Ther 2006;109:137-161
13. Loscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005;6:591-602
14. Maliepaard M, Scheffer GL, Faneyte IF, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 2001;61:3458-3464
15. Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998;95:15665-15670
16. Li M, Yuan H, Li N, et al. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human. Eur J Pharm Sci 2008;35:114-126
17. Warren MS, Zerangue N, Woodford K, et al. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacol Res 2009;59:404-413
18. Choudhuri S, Klaassen CD. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int J Toxicol 2006;25:231-259
19. Macdonald N, Gledhill A. Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans. Arch Toxicol 2007;81:553-563
20. Faber JJ, Thornburg KL, Binder ND. Physiology of placental transfer in mammals. Am Zool 1992;32:343-354
21. Leiser R, Kaufmann P. Placental structure: in a comparative aspect. Exp Clin Endocrinol 1994;102:122-134
22. Page K. The physiology of the human placenta. UCL Press Limited, London; 1993
23. Enders AC, Blankenship TN. Comparative placental structure. Adv Drug Deliv Rev 1999;38:3-15
24. Jones CJ, Fox H. Ultrastructure of the normal human placenta. Electron Microsc Rev 1991;4:129-178
25. Sugawara I, Kataoka I, Morishita Y, et al. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 1988;48:1926-1929
26. Cordon-Cardo C, O'Brien JP, Boccia J, et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990;38:1277-1287
27. Ushigome F, Takanaga H, Matsuo H, et al. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol 2000;408:1-10
28. Evseenko DA, Paxton JW, Keelan JA. Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab Dispos 2007;35:595-601
29. Kalabis GM, Petropoulos S, Gibb W, et al. Breast cancer resistance protein (Bcrp1/Abcg2) in mouse placenta and yolk sac: ontogeny and its regulation by progesterone. Placenta 2007;28(10):1073-1081
30. Pavek P, Staud F, Fendrich Z, et al. Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123. J Pharmacol Exp Ther 2003;305(3):1239-1250
31. Trezise AE, Romano PR, Gill DR, et al. The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J 1992;11(12):4291-4303
32. Novotna M, Libra A, Kopecky M, et al. P-glycoprotein expression and distribution in the rat placenta during pregnancy. Reprod Toxicol 2004;18(6):785-792
33. Kalabis GM, Kostaki A, Andrews MH, et al. Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection. Biol Reprod 2005;73(4):591-597
34. Kalabis GM, Petropoulos S, Gibb W, et al. Multidrug resistance phosphoglycoprotein (ABCB1) expression in the guinea pig placenta: developmental changes and regulation by betamethasone. Can J Physiol Pharmacol 2009;87:973-978
35. Smit JW, Huisman MT, van Tellingen O, et al. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 1999;104:1441-1447
36. Pavek P, Fendrich Z, Staud F, et al. Influence of P-glycoprotein on the transplacental passage of cyclosporine. J Pharm Sci 2001;90(10):1583-1592
37. Cygalova LH, Hofman J, Ceckova M, et al. Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility. J Pharmacol Exp Ther 2009;331:1118-1125
38. Molsa M, Heikkinen T, Hakkola J, et al. Functional role of P-glycoprotein in the human blood-placental barrier. Clin Pharmacol Ther 2005;78:123-131
39. Ceccaldi PF, Gavard L, Mandelbrot L, et al. Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model. Obstet Gynecol Int 2009;2009:726593
40. Nanovskaya T, Nekhayeva I, Karunaratne N, et al. Role of P-glycoprotein in transplacental transfer of methadone. Biochem Pharmacol 2005;69:1869-1878
41. Hemauer SJ, Nanovskaya TN, Abdel-Rahman SZ, et al. Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms. Biochem Pharmacol 2010;79:921-925
42. Hemauer SJ, Patrikeeva SL, Nanovskaya TN, et al. Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. Am J Obstet Gynecol 2010;202:383.e1-7
43. Ushigome F, Takanaga H, Matsuo H, et al. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol 2000;408(1):1-10
44. Sun M, Kingdom J, Baczyk D, et al. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 2006;27(6-7):602-609
45. Mathias AA, Hitti J, Unadkat JD. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 2005;289:R963-9
46. Gil S, Saura R, Forestier F, et al. P-glycoprotein expression of the human placenta during pregnancy. Placenta 2005;26:268-270
47. Nanovskaya TN, Nekhayeva IA, Hankins GD, et al. Transfer of methadoneacross the dually perfused preterm human placental lobule. Am J Obstet Gynecol 2008;198:126.e1-4
48. Zhang H, Wu X, Wang H, et al. Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course. Mol Pharmacol 2008;74(3):714-723
49. Coles LD, Lee IJ, Hassan HE, et al. Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice. J Pharm Sci 2009;98(8):2832-2846
50. Petropoulos S, Kalabis GM, Gibb W, et al. Functional changes of mouse placental multidrug resistance phosphoglycoprotein (ABCB1) with advancing gestation and regulation by progesterone. Reprod Sci 2007;14(4):321-328
51. Wang T, Chen M, Yan YE, et al. Growth retardation of fetal rats exposed to nicotine in utero: possible involvement of CYP1A1, CYP2E1, and P-glycoprotein. Environ Toxicol 2009;24(1):33-42
52. Evseenko DA, Murthi P, Paxton JW, et al. The ABC transporter BCRP/ ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J 2007;21:3592-3605
53. Aye IL, Paxton JW, Evseenko DA, et al. Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. Placenta 2007;28(8-9):868-877
54. Wang H, Wu X, Hudkins K, et al. Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors. Am J Physiol Endocrinol Metab 2006;291(6):E1295-304
55. Jonker JW, Buitelaar M, Wagenaar E, et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci USA 2002;99(24):15649-15654
56. Staud F, Vackova Z, Pospechova K, et al. Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J Pharmacol Exp Ther 2006;319(1):53-62
57. Petrovic V, Wang JH, Piquette-Miller M. Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats. Drug Metab Dispos 2008;36:1944-1950
58. Pollex E, Lubetsky A, Koren G. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. Placenta 2008;29:743-747
59. Myllynen P, Kummu M, Kangas T, et al. ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) in perfused term human placenta. Toxicol Appl Pharmacol 2008;232:210-217
60. Immonen E, Kummu M, Petsalo A, et al. Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic metabolism. Placenta 2010;31:641-648
61. Jonker JW, Smit JW, Brinkhuis RF, et al. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 2000;92(20):1651-1656
62. Zhou L, Naraharisetti SB, Wang H, et al. The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol 2008;73(3):949-959
63. Zhang Y, Wang H, Unadkat JD, Mao Q. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. Drug Metab Dispos 2007;35:2154-2158
64. Staud F, Vackova Z, Pospechova K, et al. Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J Pharmacol Exp Ther 2006;319:53-62
65. Cygalova L, Ceckova M, Pavek P, et al. Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat. Toxicol Lett 2008;178(3):176-180
66. Meyer zu Schwabedissen HE, Grube M, Dreisbach A, et al. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab Dispos 2006;34:524-533
67. Yeboah D, Sun M, Kingdom J, et al. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol 2006;84(12):1251-1258
68. Mathias AA, Hitti J, Unadkat JD. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 2005;289:R963-9
69. Yasuda S, Itagaki S, Hirano T, et al. Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation. Biosci Biotechnol Biochem 2005;69(10):1871-1876
70. Sawicki WT, Kujawa M, Jankowska-Steifer E, et al. Temporal/ spatial expression and efflux activity of ABC transporter, P-glycoprotein/ Abcb1 isoforms and Bcrp/Abcg2 during early murine development. Gene Expr Patterns 2006;6:738-746
71. Elbling L, Berger W, Rehberger A, et al. P-glycoprotein regulates chemosensitivity in early developmental stages of the mouse. FASEB J 1993;7:1499-1506
72. Apati A, Orban TI, Varga N, et al. High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochim Biophys Acta 2008;1778:2700-2709
73. Sarkadi B, Orban TI, Szakacs G, et al. Evaluation of ABCG2 expression in human embryonic stem cells: crossing the same river twice? Stem Cells 2010;28:174-176
74. Krishnamurthy P, Ross DD, Nakanishi T, et al. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 2004;279:24218-24225
75. Krishnamurthy P, Schuetz JD. The ABC transporter Abcg2/Bcrp: role in hypoxia mediated survival. Biometals 2005;18:349-358
76. Andersen HR, Nielsen JB, Grandjean P. Toxicologic evidence of developmental neurotoxicity of environmental chemicals. Toxicology 2000;144:121-127
77. Shen S, Zhang W. ABC transporters and drug efflux at the blood-brain barrier. Rev Neurosci 2010;21:29-53
78. Schumacher U, Mollgard K. The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain. Histochem Cell Biol 1997;108:179-182
79. Virgintino D, Errede M, Girolamo F, et al. Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development. J Neuropathol Exp Neurol 2008;67:50-61
80. Daood M, Tsai C, Ahdab-Barmada M, et al. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics 2008;39:211-218
81. van Kalken CK, Giaccone G, van der Valk P, et al. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am J Pathol 1992;141:1063-1072
82. Ek CJ, Wong A, Liddelow SA, et al. Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat. Toxicol Lett 2010; In press
83. Rosati A, Maniori S, Decorti G, et al. Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 2003;45:377-387
84. Tsai CE, Daood MJ, Lane RH, et al. P-glycoprotein expression in mouse brain increases with maturation. Biol Neonate 2002;81:58-64
85. Tachikawa M, Watanabe M, Hori S, et al. Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain. J Neurochem 2005;95:294-304
86. Schiengold M, Schwantes L, Schwartsmann G, et al. Multidrug resistance gene expression during the murine ontogeny. Mech Ageing Dev 2001;122:255-270
87. Qin Y, Sato TN. Mouse multidrug resistance 1a/3 gene is the earliest known endothelial cell differentiation marker during blood-brain barrier development. Dev Dyn 1995;202:172-180
88. Enokizono J, Kusuhara H, Sugiyama Y. Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol 2007;72:967-975
89. Clancy B, Finlay BL, Darlington RB, et al. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007;28:931-937
90. Miki Y, Suzuki T, Tazawa C, et al. Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Mol Cell Endocrinol 2005;231:75-85
91. Fakhoury M, de Beaumais T, Guimiot F, et al. mRNA expression of MDR1 and major metabolising enzymes in human fetal tissues. Drug Metab Pharmacokinet 2009;24:529-536
92. Mahmood B, Daood MJ, Hart C, et al. Ontogeny of P-glycoprotein in mouse intestine, liver, and kidney. J Investig Med 2001;49:250-257
93. Garrovo C, Rosati A, Bartoli F, et al. St John's wort modulation and developmental expression of multidrug transporters in the rat. Phytother Res 2006;20:468-473
94. Cheng X, Klaassen CD. Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. Drug Metab Dispos 2009;37:2178-2185
95. Huls M, Brown CD, Windass AS, et al. The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 2008;73:220-225
96. Pinto N, Halachmi N, Verjee Z, et al. Ontogeny of renal P-glycoprotein expression in mice: correlation with digoxin renal clearance. Pediatr Res 2005;58:1284-1289
97. Dutt A, Priebe TS, Teeter LD, et al. Postnatal development of organic cation transport and mdr gene expression in mouse kidney. J Pharmacol Exp Ther 1992;261:1222-1230
98. Rawles LA, Acuna D, Erickson RP. The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting. Mol Reprod Dev 2007;74(11):1483-1489
99. Johansson PA, Dziegielewska KM, Liddelow SA, et al. The blood-CSF barrier explained: when development is not immaturity. Bioessays 2008;30:237-248
100. Ala-Kokko TI, Myllynen P, Vahakangas K. Ex vivo perfusion of human placental cotyledon implications for anesthetic pharmacology. Int J Obstet Anesth 2000;9:26-38
101. Adamson SL, Lu Y, Whiteley KJ, et al. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 2002;250:358-373
102. Mylona P, Glazier JD, Greenwood SL, et al. Expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes during development and differentiation in the human placenta. Mol Hum Reprod 1996;2:693-698